Women’s own rating of usefulness of a treatment, reduction of symptoms, participation in usual activities and adverse effects(re- ported by women and assessors) measured at the end of treatment, during pregnancy.
• Pain intensity (pain levels);
• activities of daily living;
• days off work; or
• adverse effects for women and infants; as defined by trialist.